Please login to the form below

Not currently logged in
Email:
Password:

Eric Terhaerdt leaves AZ for Astellas

Joins as senior VP of global development operations

Eric Terhaerdt, AstellasAstellas has turned to AstraZeneca for its new senior VP of global development operations.

Eric Terhaerdt spent more than 20 years at AZ, most recently serving as VP, head of scientific and technical evaluations.

He will now lead the global direction of the drug development operations at Japan-based Astellas, working primarily in the Netherlands and the US.

Terhaerdt has extensive knowledge of the global pharmaceutical market having worked across the world for AZ in countries such as the UK, the US, Sweden, Hungary and the Czech Republic.

Dr Bernie Zeiher, executive VP, global development, welcomed Terhaerdt to the company: "His diverse international experience in drug development, strategic planning and change management will help Astellas continue to address the unmet needs of our patients."

20th January 2015

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics